|
|
|
| Observation of the Effect of Sodium Fructose Diphosphate Combined With Creatine Phosphate Acupuncture on Viral Myocarditis in Children |
| Yang Huimin |
| Vasculocardiology Deparment,Zhengzhou University Children's Hospital,Henan Provincial Children's Hospital,Zhengzhou Children's Hospital,Zhengzhou 450000,China |
|
|
|
|
Abstract Objective To observe the effect of sodium fructose diphosphate combined with creatine phosphate on children with viral myocarditis(VMC).Methods A total of 84 pediatric VMC children were collected as research subjects.They were divided into a control group and an observation group with 42 cases each.The control group was treated with sodium fructose diphosphate,and the observation group was treated with sodium fructose diphosphate combined with creatine phosphate.Compare the changes of myocardial injury markers(cTnI,CK-MB)and oxidative stress indicators(SOD,GSH)in the two groups of children before and after 14 days of treatment.The difference in efficacy between the two groups of children after 14 days of treatment and the difference in adverse drug reactions between the two groups of children within 14 days of treatment were compared.Results After 14 days of treatment,the curative effect of the observation group was significantly higher than that of the control group.The cTnI and CK-MB in the two groups of children were significantly lower than before the treatment,and the observation group was significantly lower than the control group at the same time.SOD and GSH were significantly higher than before treatment,and the observation group was significantly higher than the control group at the same time,and the difference was statistically significant(P<0.05).Within 14 days of treatment,there was no significant difference in the total incidence of adverse drug reactions between the two groups(P>0.05).Conclusion Sodium fructose diphosphate combined with creatine phosphate acupuncture is effective in treating children with VMC,can improve cardiac function,reduce myocardial oxidation,and has good drug safety.It is suitable for clinical popularization.
|
|
Received: 15 March 2020
|
|
|
|
|
|
[1] 刘曼曼,都鹏飞.小儿病毒性心肌炎的诊断与治疗[J].中华全科医学,2018,16(5):686-687.
[2] 刘春峰,魏克伦.儿科急危重症[M].北京:科学出版社,2019:121-122.
[3] 李青华,张晓英,宋靖荣.磷酸肌酸钠对病毒性心肌炎患儿心功能及细胞免疫功能的影响[J].儿科药学杂志,2019,25(6):32-34.
[4] 黄英,刘翠兰.磷酸肌酸联合免疫球蛋白对小儿病毒性心肌炎心功能及心肌酶的影响[J].药物生物技术,2019,26(1):33-36.
[5] 袁泉,张萍.磷酸肌酸钠联合心肌康颗粒治疗小儿病毒性心肌炎实效性分析[J].重庆医学,2016,45(10):1343-1344. |
| [1] |
. [J]. journal1, 2021, 41(3): 81-81. |
|
|
|
|
2021, Vol. 41 
